World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
43645
World Ranking
6737
National Ranking
3555

Alan M. Fogelman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alan M. Fogelman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 302 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alan M. Fogelman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alan M. Fogelman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 105 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Alan M. Fogelman is affiliated with the University of California, Los Angeles in the United States. Their research spans multiple fields primarily within medicine and biochemistry, genetics, and molecular biology. Subfields in which they actively publish include surgery, immunology, molecular biology, physiology, and virology.

The scientist's recent publications cover a diverse set of topics relevant to lipid metabolism, immune regulation, and vascular biology. These include:

  • Genetic Regulation of Atherosclerosis-Relevant Phenotypes in Human Vascular Smooth Muscle Cells (2020, Circulation Research)
  • Macrophage COX2 Mediates Efferocytosis, Resolution Reprogramming, and Intestinal Epithelial Repair (2022, Cellular and Molecular Gastroenterology and Hepatology)
  • Apolipoprotein mimetics in cancer (2020, Seminars in Cancer Biology)
  • The role of gut-derived oxidized lipids and bacterial lipopolysaccharide in systemic inflammation and atherosclerosis (2022, Current Opinion in Lipidology)
  • Oral 15-Hydroxyeicosatetraenoic Acid Induces Pulmonary Hypertension in Mice by Triggering T Cell-Dependent Endothelial Cell Apoptosis (2020, Hypertension)

Frequent co-authors working alongside Alan M. Fogelman include:

  • Srinivasa T. Reddy
  • Víctor Grijalva
  • A. Chattopadhyay
  • David Meriwether
  • Nasrin Dorreh

The scientist commonly publishes in the following journals and venues:

  • Current Opinion in Lipidology
  • Journal of Lipid Research
  • Circulation Research
  • Cellular and Molecular Gastroenterology and Hepatology
  • Seminars in Cancer Biology

Major research topics covered by their work include:

  • Cholesterol and Lipid Metabolism
  • Gut microbiota and health
  • HIV Research and Treatment
  • HIV-related health complications and treatments
  • Phagocytosis and Immune Regulation
  • Pancreatitis Pathology and Treatment
  • Lipoproteins and Cardiovascular Health

Best Publications

  • Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.

    Judith A. Berliner;Mohamad Navab;Alan M. Fogelman;Joy S. Frank

  • Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells

    Susan D. Cushing;Judith A. Berliner;Anthony J. Valente;Mary C. Territo

  • Antiinflammatory Properties of HDL

    Philip J. Barter;Stephen Nicholls;Kerry Anne Rye;G. M. Anantharamaiah

  • Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

    Diana M. Shih;Lingjie Gu;Yu Rong Xia;Mohamad Navab

  • Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages

    Alan M. Fogelman;Ishaiahu Shechter;Janet Seager;Martha Hokom

  • Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo

    Andrew D. Watson;Norbert Leitinger;Mohamad Navab;Kym F. Faull

  • Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins.

    T. B. Rajavashisth;A. Andalibi;M. C. Territo;J. A. Berliner

  • The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.

    Mohamad Navab;G.M. Ananthramaiah;Srinivasa T. Reddy;Brian J. Van Lenten

  • Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin Treatment

    Benjamin J. Ansell;Mohamad Navab;Susan Hama;Naeimeh Kamranpour

  • HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms

    Mohamad Navab;Srinivasa T. Reddy;Brian J. Van Lenten;Alan M. Fogelman

  • Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1

    Mohamad Navab;Susan Y. Hama;G.M. Anantharamaiah;Kholood Hassan

  • Paraoxonase-2 Is a Ubiquitously Expressed Protein with Antioxidant Properties and Is Capable of Preventing Cell-mediated Oxidative Modification of Low Density Lipoprotein

    Carey J. Ng;David J. Wadleigh;Aditya Gangopadhyay;Susan Hama

  • Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

    Christian Besler;Kathrin Heinrich;Lucia Rohrer;Carola Doerries

  • Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol

    Mohamad Navab;G.M. Anantharamaiah;Susan Hama;David W. Garber

  • Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism.

    Antonio Castrillo;Sean B Joseph;Sagar A Vaidya;Margaret Haberland

  • HDL and the Inflammatory Response Induced by LDL-Derived Oxidized Phospholipids

    Mohamad Navab;Judith A. Berliner;Ganesamoorthy Subbanagounder;Susan Hama

  • Proinflammatory high‐density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis

    Maureen McMahon;Jennifer Grossman;John FitzGerald;Erika Dahlin-Lee

  • Human Paraoxonase-3 Is an HDL-Associated Enzyme With Biological Activity Similar to Paraoxonase-1 Protein but Is Not Regulated by Oxidized Lipids

    Srinivasa T. Reddy;David J. Wadleigh;Victor Grijalva;Carey Ng

  • Oral D-4F Causes Formation of Pre-β High-Density Lipoprotein and Improves High-Density Lipoprotein–Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E–Null Mice

    Mohamad Navab;G.M. Anantharamaiah;Srinivasa T. Reddy;Susan Hama

  • Oxygenated Carotenoid Lutein and Progression of Early Atherosclerosis The Los Angeles Atherosclerosis Study

    James H. Dwyer;Mohamad Navab;Kathleen M. Dwyer;Kholood Hassan

Frequent Co-Authors

Mohamad Navab
Mohamad Navab University of California, Los Angeles
Srinivasa T. Reddy
Srinivasa T. Reddy University of California, Los Angeles
G. M. Anantharamaiah
G. M. Anantharamaiah University of Alabama at Birmingham
Judith A. Berliner
Judith A. Berliner University of California, Los Angeles
Aldons J. Lusis
Aldons J. Lusis University of California, Los Angeles
Peter A. Edwards
Peter A. Edwards University of California, Los Angeles
Gregg C. Fonarow
Gregg C. Fonarow University of California, Los Angeles
Peter Tontonoz
Peter Tontonoz University of California, Los Angeles
Linda L. Demer
Linda L. Demer University of California, Los Angeles
Margarete Mehrabian
Margarete Mehrabian University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but prefer alternative pathways to traditional medical school, there are many flexible options available online. For those who want to enter the healthcare field with a focus on administration, an online healthcare administration degree offers foundational management skills and leadership opportunities within hospitals and clinics.

Administrative careers are also supported by programs from accredited medical billing and coding schools online with financial aid. These programs prepare students for in-demand roles while providing support to help manage tuition costs.

Nursing remains a popular path, and those who wish to become registered nurses without standardized test barriers can explore a nursing school that doesn't require teas. For registered nurses looking to advance their careers, accelerated rn to np programs are available, bridging entry-level credentials to advanced practice and nurse practitioner roles.

These online options provide flexibility, financial support, and alternative routes for those passionate about healthcare but seeking a path that fits their lifestyle and goals.

Best Scientists Citing Alan M. Fogelman

Trending Scientists

Recently Published Articles